Celldex Therapeutics last closed at $32.59 (+2.97%) on 2026-10-05. Signals today: RSI rebound. Listed on Nasdaq. Trailing 12 months PER is -8.4×. Its overall grade ranks 416 of 741 stocks in Healthcare.
About this company
Celldex Therapeutics last closed at $32.59 (+2.97%) on 2026-10-05. Signals today: RSI rebound. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall B- · 416/741
Valuation grade B
Related stocks
- AmgenCompetitor
면역·염증 질환 및 항체/생물학적 제제 분야에서 경쟁
- Regeneron PharmaceuticalsCompetitor
항체 기반 바이오신약 개발 경쟁사
- SanofiCompetitor
면역질환·알레르기/염증 타깃 치료제 개발 경쟁
About Celldex Therapeutics
- What technical signals does Celldex Therapeutics (CLDX) have?
- Celldex Therapeutics current technical signals: RSI rebound.
- Is Celldex Therapeutics a cup-and-handle pattern?
- No. Celldex Therapeutics has no valid Cup signal right now.
- What published figures are available for Celldex Therapeutics?
- Market cap: $2.17B. Trailing 12 months PER: -8.4×. Latest quarter PBR: 3.55×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-06 dataset
Turn what you saw on this name into a strategy
Ask Q about Celldex Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy